Karyopharm Therapeutics (KPTI) PT Raised to $11 at Wedbush

July 5, 2019 7:31 AM EDT
Get Alerts KPTI Hot Sheet
Price: $8.37 -4.78%

Rating Summary:
    14 Buy, 1 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 19
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten raised the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $11.00 (from $6.00) while maintaining an Outperform rating following XPOVIO approval.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change